Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

FLGT

Fulgent Genetics (FLGT)

Fulgent Genetics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FLGT
DateHeureSourceTitreSymboleSociété
04/06/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
03/06/202414h00Business WireFulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck CancerNASDAQ:FLGTFulgent Genetics Inc
24/05/202414h00Business WireFulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
16/05/202422h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FLGTFulgent Genetics Inc
14/05/202422h05Business WireMoffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer TherapeuticsNASDAQ:FLGTFulgent Genetics Inc
03/05/202413h00Business WireFulgent Reports First Quarter 2024 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
11/04/202422h05Business WireFulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024NASDAQ:FLGTFulgent Genetics Inc
28/02/202413h00Business WireFulgent Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
13/02/202414h00Business WireFulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024NASDAQ:FLGTFulgent Genetics Inc
10/02/202400h09Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:FLGTFulgent Genetics Inc
09/02/202414h31PR Newswire (US)Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic TestingNASDAQ:FLGTFulgent Genetics Inc
13/12/202303h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FLGTFulgent Genetics Inc
14/11/202322h30Business WireFulgent to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:FLGTFulgent Genetics Inc
03/11/202321h05Business WireFulgent Shares Data from Two Poster Presentations at SITC 2023 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
03/11/202312h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FLGTFulgent Genetics Inc
03/11/202312h00Business WireFulgent Reports Third Quarter 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
25/10/202314h00Business WireFulgent Announces Two Poster Presentations at SITC 2023 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
17/10/202314h00Business WireFulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023NASDAQ:FLGTFulgent Genetics Inc
04/08/202313h00Business WireFulgent Reports Second Quarter 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
24/07/202322h05GlobeNewswire Inc.Exagen Inc. Appoints Paul Kim to Board of DirectorsNASDAQ:FLGTFulgent Genetics Inc
18/07/202314h00Business WireFulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023NASDAQ:FLGTFulgent Genetics Inc
06/06/202323h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLGTFulgent Genetics Inc
05/06/202314h30Business WireFulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various CancersNASDAQ:FLGTFulgent Genetics Inc
18/05/202322h59Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FLGTFulgent Genetics Inc
18/05/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLGTFulgent Genetics Inc
18/05/202322h05Business WireFulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2023 Annual MeetingNASDAQ:FLGTFulgent Genetics Inc
05/05/202313h00Business WireFulgent Reports First Quarter 2023 Financial ResultsNASDAQ:FLGTFulgent Genetics Inc
20/04/202322h05Business WireFulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023NASDAQ:FLGTFulgent Genetics Inc
11/04/202314h00PR Newswire (US)Mission Bio Partners with Fulgent Genetics to Broaden Accessibility of Single-Cell Multi-Omics for Drug Development and Clinical ResearchNASDAQ:FLGTFulgent Genetics Inc
03/04/202312h17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FLGTFulgent Genetics Inc
 Showing the most relevant articles for your search:NASDAQ:FLGT